Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.
Relievant is a Minnesota-based medical device company that develops and manufactures minimally invasive implants for the diagnosis and treatment of vertebrogenic pain.